Opens in a new tab

Pan-Cancer

Marcas
Marcas
Ver todas las marcas
Tecnologías
Tecnologías
Ver todas las tecnologías
Pan-Cancer
Marcas
Marcas
Ver todas las marcas
Tecnologías
Tecnologías
Ver todas las tecnologías

Productos de Pan-Cancer

SureSelect Cancer CGP Assay

Targeted-enrichment NGS pan-cancer panel for comprehensive genomic profiling (CGP) of solid tumours. Designed to detect somatic variants at DNA level (SNVs, indels, CNVs, translocations) and RNA level (gene fusions), as well as to assess complex immuno-oncology biomarkers such as tumour mutational burden (TMB), microsatellite instability (MSI) and homologous recombination deficiency (HRD). Detailed Description Operating principle…
Agilent
HRD
Next Generation Sequencing (NGS)

MSK-ACCESS® powered with SOPHiA DDM™

In-house liquid biopsy solution based on hybrid-capture next-generation sequencing (NGS) technology for the ultrasensitive detection of somatic alterations in circulating cell-free DNA from plasma. Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it implements a robust matched tumor-normal sequencing approach (plasma cfDNA + white blood cell DNA) to filter germline variants and mutations…
SOPHIA Genetics
Digestive System
Next Generation Sequencing (NGS)

MSK-IMPACT® / MSK-IMPACT® FLEX

Decentralised, in-house comprehensive genomic profiling (CGP) solution for solid tumours, based on hybrid capture next-generation sequencing (NGS). Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it features a robust matched tumour-normal sequencing approach for filtering germline variants and clonal haematopoiesis. Detailed description Operating principle The decentralised MSK-IMPACT® powered with SOPHiA DDM™ solution enables…
SOPHIA Genetics
Digestive System
Next Generation Sequencing (NGS)

Hedera Profiling 1 FFPE Test Panel (HP1)

In‑house targeted enrichment NGS panel for pan‑cancer solid tumor profiling. It analyzes 115 genes (79 with complete CDS) with ESCAT I, II and III clinical evidence. Includes library preparation through a flexible workflow that allows processing FFPE and cfDNA samples together or separately. Detects SNVs, Indels, CNVs, fusions, structural variants and MSI. Detailed Description PRINCIPLE…
HederaDx
Liquid Biopsy
Next Generation Sequencing (NGS)

OncoDEEP®

The Oncodeep kit from OncoDNA offers a comprehensive solution for identifying mutations, variants, and fusions in the somatic line of genes associated with solid tumors through Next-Generation Sequencing (NGS). Designed by oncology experts, this kit includes the most relevant and complete gene panel in the field of cancer, consisting of 638 genes, which allows for…
OncoDNA
Fusions
Next Generation Sequencing (NGS)

FusionPlex® Pan Solid Tumor v2

NGS kit for the study of solid tumors associated genes.
Archer Dx
Fusions
Next Generation Sequencing (NGS)